Arrowgrass Capital Partners (US)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-50,700
Closed -$7.08M 306
2017
Q4
$7.08M Buy
50,700
+49,642
+4,692% +$6.91M 0.07% 266
2017
Q3
$13.8M Buy
1,058
+461
+77% +$61.1K 0.1% 232
2017
Q2
$7.9M Buy
597
+260
+77% +$33.2K 0.06% 336
2017
Q1
$4.2M Sell
337
-1,024
-75% -$122K 0.04% 348
2016
Q4
$15.7M Buy
1,361
+341
+33% +$39.4K 0.18% 116
2016
Q3
$12M Sell
1,020
-413
-29% -$50.1K 0.16% 123
2016
Q2
$17.4M Sell
1,433
-143
-9% -$16.2K 0.18% 82
2016
Q1
$17.1M Sell
1,576
-1,002
-39% -$104K 0.2% 83
2015
Q4
$26.5M Buy
2,578
+186
+8% +$18.7K 0.32% 42
2015
Q3
$22.3M Buy
2,392
+97
+4% +$9.38K 0.42% 45
2015
Q2
$22.4M Sell
2,295
-3,597
-61% -$360K 0.33% 57
2015
Q1
$59.3M Sell
5,892
-423,608
-99% -$43.1M 0.91% 16
2014
Q4
$44.9M Buy
429,500
+413,500
+2,584% +$43.6M 0.8% 19
2014
Q3
$1.71M Buy
+16,000
New +$1.66M 0.04% 194

Other funds holding JNJ

Arrowgrass Capital Partners (US)'s JNJ Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) reduced its Johnson & Johnson (JNJ) stake by 58% in Q4 2019, selling an estimated $711K and leaving 3,841 shares worth $560K. The position accounts for 0.15% of the portfolio, ranked #52.

Arrowgrass Capital Partners (US) first reported a position in JNJ in Q3 2014 and has held it in 18 quarters since. The position peaked at $24.5M in Q3 2015. 2,990 funds tracked by Wall St. Rank hold JNJ as of Q4 2019.

  • Arrowgrass Capital Partners (US) held 3,841 shares of Johnson & Johnson worth $560K as of Q4 2019.
  • Arrowgrass Capital Partners (US) sold 5,241 Johnson & Johnson shares in Q4 2019, an estimated $711K.
  • Johnson & Johnson made up 0.15% of Arrowgrass Capital Partners (US)'s portfolio in Q4 2019, its #52 holding.
  • Arrowgrass Capital Partners (US) first reported a position in Johnson & Johnson in Q3 2014 and has held it in 18 quarters since.
  • Arrowgrass Capital Partners (US)'s Johnson & Johnson position peaked at $24.5M in Q3 2015.
  • 2,990 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.